Advertisement

Cytokines in Relation to Inflammatory Skin Disease

  • K. A. Brown
  • B. A. Ellis
  • D. C. Dumonde
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 87 / 1)

Abstract

Cytokines are soluble, non-antibody proteins that orchestrate many immunological reactions including cell-mediated immune responses; lymphocyte activation, proliferation and differentiation; and haemopoietic mechanisms. The term encompasses the mediators derived from activated T-lymphocytes, i.e. lymphokines (LKs) (DUMONDE et al. 1969); monocytes/macrophages, i.e. monokines (MKs) (WAKSMAN and NAMBA 1976); and those mediators whose cellular origin is known to be more diverse, e.g. interferons. All cytokines were originally described in terms of their biological activity(ies) with little knowledge of their chemical structure. From the application of more precise biological assays, immunoassays, and more sensitive biochemical techniques, it became apparent that different lymphokine or cytokine activities could actually be mediated by the same molecule(s). Consequently, at the 2nd International Workshop on Lymphokines in 1979, the generic term “interleukin” (“between leucocytes”) was introduced to bring together some of these mediators (AARDEN et al. 1979). Historically, the concept of special mediators of immunological regulation, rather than direct cellular or anti-body-mediated mechanisms, evolved from studies of delayed-type hypersensitivity and inflammation, and has been extensively documented (ADELMAN et al. 1979; ROCKLIN et al. 1980; WATSON 1981; HANSON et al. 1982; DUMONDE and HAMBLIN 1983).

Keywords

Atopic Dermatitis Visceral Leishmaniasis Inflammatory Skin Disease Dermatological Disorder Human Epidermal Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aarden LA, Brimner TK, Cerottini JC et al. (1979) Letter to the editor: revised nomenclature for antigen non-specific T-cell proliferation and helper factors. J Immunol 123:2928–2929Google Scholar
  2. Adelman NE, Hammond ME, Cohen S, Dvorak HF (1979) Lymphokines as inflammatory mediators. In: Cohen S, Pick E, Oppenheim JJ (eds) Biology of the lymphokines. Academic, New York, pp 13–58Google Scholar
  3. Albrightson CR, Baenziger NL, Needleman P (1985) Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1. J Immunol 135:1872–1877PubMedGoogle Scholar
  4. Alcocer-Varela J, Alarcon-Segovia D (1982) Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 69:1388–1396PubMedGoogle Scholar
  5. Alcocer-Varela J, Martinez-Cordero E, Alarcon-Segovia D (1985) Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma. Clin Exp Immunol 59:666–672PubMedGoogle Scholar
  6. Allison AC, Denman AM, Barnes RD (1971) Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet II:135–140Google Scholar
  7. Ansel J, Luger TA, Green I (1983) The effect in vitro and in vivo of UV irradiation on the production of ETAF activity by human and murine keratinoeytes. J Invest Dermatol 81:519–523PubMedGoogle Scholar
  8. Ansel J, Luger TA, Klock A, Hochstein D, Green I (1984) The effect of in vivo UV irradiation on the production of IL-1 by murine macrophages and P388D1 cells. J Immunol 133:1350–1355PubMedGoogle Scholar
  9. Ansel JC, Luger TA, Lowry DR, Mountz JD (1986) Expression of IL-1 in murine kerati-noeytes. J Invest Dermatol 87:127Google Scholar
  10. Ansel JC, Luger TA, Green I (1987) Fever and increased serum IL-1 activity as a systemic manifestation of acute phototoxicity in New Zealand white rabbits. J Invest Dermatol 89:32–37PubMedGoogle Scholar
  11. Bell TV, Harley CB, Stetsko D, Sander DN (1987) Expression of mRNA homologous to interleukin 1 in human epidermal cells. J Invest Dermatol 88:375–379PubMedGoogle Scholar
  12. Belsito DV, Dersarkissian RM, Thorbecke GJ, Baer RL (1987) Reversal by lymphokines of the age-related hyperresponsiveness to contact sensitization and reduced la expression on Langerhans cells. Arch Dermatol Res 279:576–580Google Scholar
  13. Bevilacqua MP, Pober JS, Wheeler MC, Contran RS, Gimbrone MA Jr (1985) Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte lines. J Clin Invest 76:2003–2011PubMedGoogle Scholar
  14. Billiau A (1986) BSF-2 is not just a differentiation factor. Nature 324:415PubMedGoogle Scholar
  15. Boker BS, Swain AF, Fry L, Valdimarsson H (1984) Epidermal T lymphocytes and HLA-DR expression in psoriasis. Br J Dermatol 110:555–564Google Scholar
  16. Borel JF, Feurer C, Magnee C, Stahelin H (1977) Effects of the new antilymphocyte peptide cyclosporin A in animals. Immunology 32:1017–1025PubMedGoogle Scholar
  17. Bos JD, Krieg SR (1985) Psoriasis infiltrating cell immunophenotype: changes induced by PUVA or corticosteroid treatment in T-cell subsets, Langerhans cells and interdigitating cells. Acta Derm Venereol (Stockh) 65:390–397Google Scholar
  18. Brain S, Camp R, Dowd P, Kobza Black A, Greaves MW (1984) The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J Invest Dermatol 83:70–77PubMedGoogle Scholar
  19. Camp RDR, Fincham NJ, Cunningham FM, Greaves MW, Morris J, Chu A (1986) Psoriatic skin lesions contain biologically active amounts of an interleukin 1-like compound. J Immunol 137:3469–3474PubMedGoogle Scholar
  20. Carvalho EM, Badaro R, Reed SG, Jones TC, Johnson WD (1985) Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis. J Clin Invest 76:2066–2069PubMedGoogle Scholar
  21. Cavender DE, Haskard DO, Joseph B, Ziff M (1986) Interleukin 1 increases the binding of human B and T lymphocytes to endothelial cell monolayers. J Immunol 136:203–207PubMedGoogle Scholar
  22. Clark SC, Kamen R (1987) The human hematopoietic colony stimulating factors. Science 236:1229–1237PubMedGoogle Scholar
  23. Clark-Lewis I, Aebersold R, Ziltener H, Schrader JW, Hood LE, Kent SBH (1986) Automated chemical synthesis of a protein growth factor for hemopoietic cells, interleukin-3. Science 231:134–139PubMedGoogle Scholar
  24. Cybulsky MI, Colditz IG, Movat HZ (1985) Interleukin 1 activity in the local recruitment of PMNs: its potential role in endotoxin induced acute inflammation. Fed Proc 44:1260 (abstr)Google Scholar
  25. Danner M, Luger TA (1987) Human keratinocytes and epidermoid carcinoma cell lines produce a cytokine with interleukin 3-like activity. J Invest Dermatol 88:353–361PubMedGoogle Scholar
  26. Dauphine MJ, Kipper BS, Wolfsy D, Talal N (1981) Interleukin-2 deficiency is a common feature of autoimmune mice. J Immunol 127:2483–2487Google Scholar
  27. Dayer JM (1982) Effects of retinoids on prostaglandin E2 (PGE2) and mononuclear cell factor (MCF) production by human monocyte cultures. Clin Res 30:469 (abstr)Google Scholar
  28. Dayne R, Samlowski WE, Burnhan DK, Gahring LC, Roberts LK (1986) Immunobiological consequences of acute and chronic UV exposure. Curr Probl Dermatol 15:177–194Google Scholar
  29. Dinarello CA (1984 a) Interleukin 1. Rev Infect Dis 6:51–55Google Scholar
  30. Dinarello CA (1984 b) Interleukin 1 and the pathogenesis of the acute-phase response. N Engl J Med 311:1413–1418Google Scholar
  31. Dower SK, Urdel DL (1987) The interleukin-1 receptor. Immunol Today 8:46–51Google Scholar
  32. Drebin AJ, Schatten S, Tominga A (1983) Effect of ultraviolet radiation-induced impairment of antigen-presenting cell function at the cellular and molecular level. In: Parrish JA (ed) The effect of ultraviolet radiation on the immune system. Johnson and Johnson, New York, p 123Google Scholar
  33. Dumonde DC, Wolstencroft RA, Panayi GS, Matthew M, Morley J, Howson WT (1969) Lymphokines: non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature 224:38–42PubMedGoogle Scholar
  34. Dumonde DC, Hamblin AS (1983) Lymphokines. In: Holborow EJ, Reeves WG (eds) Immunology in medicine, 2nd edn. Academic, New York, pp 121–150Google Scholar
  35. Durum SK, Schmidt JA, Oppenheim JJ (1985) Interleukin 1: an immunological perspective. Ann Rev Immunol 3:263–287Google Scholar
  36. Elliot YF, Lin Y, Mizel SB, Blackley RC, Harnish DG, Paetkau Y (1984) Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science 226:1439–1441Google Scholar
  37. Elments C, Rick E, Urda G, Fujiwara H, Ellner J (1986) UVB radiation inhibits accessory cell signals required for mitogenic responses of human T lymphocytes. J Invest Dermatol 86:473 (abstr)Google Scholar
  38. Fung MC, Hapel AJ, Ymer S, et al. (1984) Molecular cloning of cDNA for murine inter-leukin 3. Nature 307:233–237PubMedGoogle Scholar
  39. Gahring L, Baltz M, Pepys MB, Daynes R (1984) Effect of ultraviolet radiation on the production of epidermal cell thymocyte-activating factor/interleukin 1 in vivo and in vitro. Proc Natl Acad Sci USA 81:1198–1202PubMedGoogle Scholar
  40. Gahring LC, Daynes RA (1986) Desensitization of animals to the inflammatory effects of ultraviolet radiation is mediated through mechanisms which are distinct from those responsible for endotoxin tolerance. J Immunol 136:2868–2874PubMedGoogle Scholar
  41. Gery I, Gershon RK, Waksman BH (1971) Potentiation of cultured mouse thymocyte responses by factors released by peripheral leukocytes. J Immunol 107:1778PubMedGoogle Scholar
  42. Gery I, Davies P, Derr J, Krett N, Barranger JA (1981) Relationship between production and release of lymphocyte-activating factor (interleukin 1) by murine macrophages. I. Effects of various agents. Cell Immunol 64:293–303PubMedGoogle Scholar
  43. Gilchrist BA, Sauder DN (1984 a) Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte activating factor (ETAF): implications for cellular ageing. J Invest Dermatol 82:439 (abstr)Google Scholar
  44. Gilchrist BA, Sauder DN (1984 b) Autocrine growth stimulation of human keratinocytes by epidermal cell-derived thymocyte activating factor (ETAF): implications for cellular ageing. Clin Res 32:585AGoogle Scholar
  45. Gillis S, Stull DD (1982) Tumor and hybridoma cell line interleukin-2 production. In: Pick E (ed) Lymphokines, vol 5. Academic, New York, pp 371–385Google Scholar
  46. Gillis S, Watson J (1980) Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin-2 producer human leukemic T-cell line. J Exp Med 152:1709–1719PubMedGoogle Scholar
  47. Gillis S, Scheid M, Watson J (1980) Biochemical and biological characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of interleukin-2 producing T-cell lymphomas. J Immunol 125:2570–2578PubMedGoogle Scholar
  48. Gordon J, MacLean LD (1965) A lymphocyte-stimulating factor produced in vitro. Nature 208:795–796PubMedGoogle Scholar
  49. Gray PW, Leung DW, Pennica D, et al. (1982) Expression of human immune interferon cDNA in E. coli and monkey cells. Nature 295:503–508PubMedGoogle Scholar
  50. Greene MI, Sy MS, Kripke ML, Benacerraf B (1979) Impairment of antigen-presenting function by ultraviolet radiation. Proc Natl Acad Sci USA 76:6591–6595PubMedGoogle Scholar
  51. Hanifin JM, Lobitz WC Jr (1977) Newer concepts of atopic dermatitis. Arch Dermatol 113:667–670Google Scholar
  52. Hanson JM, Rumjanek VM, Morley J (1982) Mediators of cellular immune reactions. Pharmacol Ther 17:165–198PubMedGoogle Scholar
  53. Harber LC, Bickers DR (1981) Photosensitivity diseases. Principles of diagnosis and management. Saunders, PhiladelphiaGoogle Scholar
  54. Harper JI, Keat ACS, Staughton RCD (1984) Cyclosporin for psoriasis. Lancet 11:981–988Google Scholar
  55. Hauser C, Saurat JH, Schmitt A, et al. (1986) Interleukin 1 is present in normal human epidermis. J Immunol 136:3317–3322PubMedGoogle Scholar
  56. Hawk JLM, Black AK, Jaenicke KF, et al. (1983) Increased concentrations of arachidonic acid, prostaglandin E2, D2 and 6-oxo-F1α and histamine in human skin following UVA irradiation. J Invest Dermatol 80:476–498Google Scholar
  57. Hirano T, Yasukawa K, Harada H, et al. (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324:73–76PubMedGoogle Scholar
  58. Holbrook NJ, Smith KA, Fornace AJ, Comeau CC, Wiskocil RL, Crabtree GR (1984) T-cell growth factor: complete nucleotide sequence and organisation of the gene in normal and malignant cells. Proc Natl Acad Sci USA 81:1634–1638PubMedGoogle Scholar
  59. Howard M, Farrar J, Hilfiker M, et al. (1982) Identification of a T-cell derived B-cell growth factor distinct from interleukin 2. J Exp Med 155:914–923PubMedGoogle Scholar
  60. Ihle JN, Rebar L, Keller J, Lee JC, Hapel AJ (1982) Interleukin 3: possible roles in the regulation of lymphocyte differentiation and growth. Immunol Rev 63:11–32Google Scholar
  61. Kampschmidt RF, Pulliam LA, Merriman CR (1978) Further similarities of endogenous pyrogen and leukocytic endogenous mediator. Am J Physiol 243:E332–E337Google Scholar
  62. Kasakura S, Lowenstein L (1965) A factor stimulating DNA synthesis derived from the medium of leucocyte cultures. Nature 208:794–795PubMedGoogle Scholar
  63. Kermani-Arob V, Hirji K, Ahmed AR, Fahey JL (1984) Deficiency of interleukin-2 production and interleukin-2 receptor expression on peripheral blood leukocytes after phytohaemagglutinin stimulation in pemphigus. J Invest Dermatol 83:101–104Google Scholar
  64. Kinashi T, Harada N, Severinson E, et al. (1986) Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 324:70–73PubMedGoogle Scholar
  65. Kobayashi Y, Asada M, Higuchi M, Osawa T (1982) Human T-cell hybridomas producing lymphotoxin and migration inhibitory factor. J Immunol 128:417–422Google Scholar
  66. Kragballe K, Marcelo CL, Voorhees J J, Sauder DN (1987) Formation of epidermal cell thymocyte-activating factor (ETAF) from cultured human keratinoeytes from normal and uninvolved psoriatic skin. J Invest Dermatol 88:8–10PubMedGoogle Scholar
  67. Kunkell SL, Chensue SW (1985) Arachidonic acid metabolites regulate interleukin-1 production. Biochem Biophys Res Commun 128:892–897Google Scholar
  68. Kuntz-Crow M, Kunkel MG (1982) Human dendritic cells: major stimulators of the autologous and allogeneic mixed leucocyte reactions. Clin Exp Immunol 49:338–346Google Scholar
  69. Kupper TS, McGuire J (1986) Hydrocortisone reduces both constitutive and UV-elicted release of epidermal thymocyte activating factor (ETAF) by cultured keratinoeytes. J Invest Dermatol 87:570–573PubMedGoogle Scholar
  70. Kupper T, Gubler U, Ballard D, et al. (1986) Identification of interleukin 1 mRNA in human and murine keratinocyte. Clin Res 34:640–647Google Scholar
  71. Leonard WJ, Depper JM, Crabtree GR, et al. (1984) Molecular cloning and expression of cDNAs for the human interleukin-2 receptor. Nature 311:626–631PubMedGoogle Scholar
  72. Leung DYM, Saryan JA, Frankel R, Lareau M, Geha RS (1983) Impairment of the autologous mixed lymphocyte reaction in atopic dermatitis. J Clin Invest 72:1482–1486PubMedGoogle Scholar
  73. Liang S-M, Thatcher DR, Wang C-M, Allet B (1986) Studies of structure-activity relation-ships of human interleukin-2. J Biol Chem 261:334–337PubMedGoogle Scholar
  74. Linker-Israeli M, Bahke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA (1983) Defective production of interleukin-1 and interleukin-2 in patients with systemic lupus erythematosus (SLE). J Immunol 130:2651–2655PubMedGoogle Scholar
  75. Lomedico PT, Gubler U, Hellmann CP, et al. (1984) Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature 312:458–462PubMedGoogle Scholar
  76. Lopez AF, Begley CG, Williamson DJ, et al. (1986) Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells. J Exp Med 163:1085–1099PubMedGoogle Scholar
  77. Lotze MT, Matory YL, Ettinghausen SE, et al. (1985) In vivo administration of purified human interleukin 2. II. Half-life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL-2. J Immunol 135:2865–2875PubMedGoogle Scholar
  78. Luger TA, Oppenheim J J (1983) Characteristics of interleukin 1 and epidermal cell-derivedthymocyte activating factor. Adv Inflam Res 5:1–25Google Scholar
  79. Luger TA, Stadler BM, Katz SI, et al. (1981) Epidermal cell (keratinocyte)-derived thymocyte-activating factor (ETAF). J Immunol 127:1493–1498PubMedGoogle Scholar
  80. Luger TA, Sztein MB, Schmidt J, et al. (1983 a) Properties of murine and human epidermal cell-derived thymocyte-activating factor. Fed Proc 42:2772–2776Google Scholar
  81. Luger TA, Charon J A, Colot M, et al. (1983 b) Chemo tactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells. J Immunol 131:816–820Google Scholar
  82. Luger TA, Wirth U, Koeck A (1985) Epidermal cells synthesize a cytokine with interleukin 3 like properties. J Immunol 134:915–919PubMedGoogle Scholar
  83. Maini RN, Bryceson ADM, Wolstencroft RA, Dumonde DC (1969) Lymphocyte mitogenic factor in man. Nature 224:43–44PubMedGoogle Scholar
  84. Majwski S, Tigalonowa M, Jablonska S, Polakowski I, Janczura E (1987) Serum samples from patients with active psoriasis enhance lymphocyte-induced angiogenesis and modulate endothelial cell proliferation. Arch Dermatol 123:221–225Google Scholar
  85. Mallet AI, Cunningham FM (1985) Structural determination of platelet activating factor in psoriasis. Biochem Biophys Res Commun 126:192–199PubMedGoogle Scholar
  86. March CJ, Mosley B, Larsen A, et al. (1985) Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 315:641–647PubMedGoogle Scholar
  87. McGuire J, Longdon R, Kupper T (1986) Interleukin-1 mRNA increases following irradiation with ultraviolet-B. J Invest Dermatol 87:155 (abstr)Google Scholar
  88. Metcalf D (1985) The granulocyte-macrophage colony stimulating factors. Science 229:16–22PubMedGoogle Scholar
  89. Miossec P, Yu C-L, Ziff M (1984) Lymphocyte chemotactic activity of human interleukin 1. J Immunol 133:2007–2011PubMedGoogle Scholar
  90. Miossec P, Cavender D, Ziff M (1986) Production of interleukin 1 by human endothelial cells. J Immunol 136:2486–2491PubMedGoogle Scholar
  91. Mizoguchi M, Furusawa S, Okitsu S, Yoshino K (1985) Macrophage-derived interleukin 1 activity in atopic dermatitis. J Invest Dermatol 84:303–311Google Scholar
  92. Namiuchi S, Kumagai S, Sano H, et al. (1986) A human T cell line established from a patient with Sezary syndrome. J Immunol Methods 94:215–224PubMedGoogle Scholar
  93. Nikaido T, Shimizu A, Ishida N, et al. (1984) Molecular cloning of cDNA encoding human interleukin-2 receptor. Nature 311:631–635PubMedGoogle Scholar
  94. Noonan FP, Kripke ML, Pederson GM, Green MI (1981) Suppression of contact sensitivity of mice by ultraviolet radiation is associated with defective antigen presentation. Immunology 43:527–533PubMedGoogle Scholar
  95. Oppenheim JJ, Kovacs EJ, Matsushima K, Durum SK (1986) There is more than one interleukin 1. Immunol Today 7:45–56Google Scholar
  96. Parrish JA, Kripki ML, Warwick ML (1984) Photoimmunology. Plenum, New YorkGoogle Scholar
  97. Pennica D, Nedwin GE, Haylick JS, et al. (1984) Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312:724–729PubMedGoogle Scholar
  98. Pincus H, Mehregan AM (1966) The primary histological lesion of seborrhaeic dermatitis and psoriasis. J Invest Dermatol 46:109–116Google Scholar
  99. Pober JS, Bevilacqua MP, Mendrick DL, Lapierre LA, Fiers W, Gimbrone MA Jr (1986) Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 136:1680–1687PubMedGoogle Scholar
  100. Pohlman TH, Stanness KA, Beatty PG, Ochs MD, Harlan JM (1986) An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumour necrosis factor — increases neutrophil adherence by a CDW 18-dependent mechanism. J Immunol 136:4548–4553PubMedGoogle Scholar
  101. Politstein-Willinger E (1985) Normalization of defective interleukin 1 and interleukin 2 production in patients with pemphigus vulgaris following chrysotherapy. Clin Exp Immunol 62:705–714Google Scholar
  102. Rasanen L, Lehto M, Reunola T, Jansen C, Lehtinen M, Leinikki P (1987 a) Langerhans cell- and T-lymphocyte functions in patients with atopic dermatitis with disseminated cutaneous herpes simplex virus infection. J Invest Dermatol 89:15–18Google Scholar
  103. Rasanen L, Lehto M, Reunala T, Jansen C, Leinikki P (1987 b) Decreased monocyte production of interleukin-1 and impaired lymphocyte proliferation in atopic dermatitis. Arch Dermatol Res 279:215–218Google Scholar
  104. Robb RJ, Smith KA (1981) Heterogeneity of human T-cell growth factor(s) due to variable glycosylation. Mol Immunol 18:1087–1094PubMedGoogle Scholar
  105. Robb RJ (1984) Interleukin 2: the molecule and its function. Immunol Today 5:203–209Google Scholar
  106. Robb RJ, Kutny RM, Panico M, Morris HR, Chowdrey V (1984) Amino acid sequence and post-translational modification of human interleukin-2. Proc Natl Acad Sci USA 81:6456–6490Google Scholar
  107. Robertson B, Gahring L, Newton R, Daynes R (1987) In vivo administration of interleukin 1 to normal mice depresses their capacity to elicit contact hypersensitivity responses: prostaglandins are involved in this modification of immune function. J Invest Dermatol 88:380–387PubMedGoogle Scholar
  108. Rocklin RE, Bendtzen K, Greineder D (1980) Mediators of immunity: lymphokines and monokines. Adv Immunol 29:55–136PubMedGoogle Scholar
  109. Rosenberg SA, Grimm EA, McGrogan M, et al. (1984) Biological activity of recombinant human interleukin-2 produced in Escherichia coli. Science 223:1412–1415PubMedGoogle Scholar
  110. Rosenstreich DL, Wahl SM (1979) Cellular sources of lymphokines. In: Cohen S, Pick E, Oppenheim JJ (eds) Biology of the lymphokines. Academic, New York, pp 210–242Google Scholar
  111. Rosenwasser LJ, Dinarello CA, Rosenthal AS (1979) Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T cell antigen recognition by human leukocytic pyrogen. J Exp Med 150:709–714PubMedGoogle Scholar
  112. Rullan PP, Barr RJ, Cole GW (1984) Cyclosporine and murine allergic contact dermatitis. Arch Dermatol 120:1179–1186PubMedGoogle Scholar
  113. Sagar AD, Sehgal PB, Slate DL, Ruddle FH (1982) Multiple human interferon genes. J Exp Med 156:744–755PubMedGoogle Scholar
  114. Sakane T, Suzuki N, Ueda Y, et al. (1986) Analysis of interleukin-2 activity in patients with Behcet’s disease. Arthritis Rheum 29:371–378PubMedGoogle Scholar
  115. Sandborg CI, Berman MA, Andrews BS, Friou GJ (1985) Interleukin-1 production by mononuclear cells from patients with scleroderma. Clin Exp Immunol 60:294–302PubMedGoogle Scholar
  116. Sandborg CI, Berman MA, Andrews BS, Mirick GR, Friou GJ (1986) Increased production of an interleukin 1 (IL-1) inhibitor with fibroblast stimulating activity by mononuclear cells from patients with scleroderma. Clin Exp Immunol 66:312–319PubMedGoogle Scholar
  117. Sauder DN, Katz SI (1982) Immune modulation by epidermal cell products: possible role of ETAF in inflammatory and neoplastic skin diseases. J Am Acad Dermatol 7:651–654PubMedGoogle Scholar
  118. Sauder DN, Dinarello CA, Morhenn VB (1984) Langerhans cell production of interleukin-1. J Invest Dermatol 82:605–607PubMedGoogle Scholar
  119. Schimpl A, Wecker E (1972) Replacement of T-cell function by a T-cell product. Nature 237:15–17Google Scholar
  120. Schleimer RP, Rutledge BK (1986) Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, and tumour-promoting phorbol diesters. J Immunol 136:649–654PubMedGoogle Scholar
  121. Schmitt A, Hauser C, Janin F, Dayer JM, Saurat JH (1986) Normal rat epidermis contains high amounts of natural tissue IL-1. Biochemical analysis by HPLC identifies a MW17 Kd form with a pI 5.7 and a MW 30 Kd form. Lymphokine Res 5:105–117PubMedGoogle Scholar
  122. Schmitt A, Hauser C, Didierjean L, Merot Y, Dayer JM, Saurat JH (1987) Systemic administration of detretinate increases epidermal interleukin 1 in the rat. Br J Dermatol 116:615–622PubMedGoogle Scholar
  123. Schrader JW, Clark-Lewis I (1981) T-cell hybridoma-derived regulatory factors. I. Production of T-cell growth factor following stimulation with concanavalin A. J Immunol 126:1101–1105PubMedGoogle Scholar
  124. Schroder JM, Christophers E (1985) Identification of a new and potent chemotaxin in psoriatic scales. J Invest Dermatol 84:444–451Google Scholar
  125. Schwarz T, Urbanska A, Gschnait F, Luger TA (1986) Inhibition of the induction of contact hypersensitivity by an UV mediated epidermal cytokine. J Invest Dermatol 87:289PubMedGoogle Scholar
  126. Schwarz T, Urbanska A, Gschnait F, Luger T (1987) Biological and biochemical properties of an UVB induced cell derived inhibitor of CHS. J Immunol 138:1457–1464PubMedGoogle Scholar
  127. Seigel LJ, Harper ME, Wong-Staal F, Gallo RC, Nash WG, O’Brien SJ (1984) Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1. Science 223:175–178PubMedGoogle Scholar
  128. Shidani B, Milon G, Marchal G, Truffa-Bachi P (1984) Cyclosporin A inhibits the delayed-type hypersensitivity reaction: impaired production of early pro-inflammatory mediator(s). Eur J Immunol 14:314–318PubMedGoogle Scholar
  129. Sieff CA, Tsai S, Faller DV (1987) Interleukin 1 induces cultured human endothelial cell production of granulocyte-macrophage colony-stimulating factor. J Clin Invest 79:48–51PubMedGoogle Scholar
  130. Smith KA (1984) Interleukin 2. Ann Rev Immunol 2:319–333Google Scholar
  131. Smith KA (1987) The two-chain structure of high affinity IL-2 receptors. Immunol Today 8:11–13Google Scholar
  132. Smolen JS, Chused TM, Novotny EA, Steinberg AD (1982) The human autologous mixed lymphocyte reaction. J Immunol 129:1050–1053PubMedGoogle Scholar
  133. Swain SL, Howard M, Kappler J, et al. (1983) Evidence for two distinct classes of murine B cell growth factors which have activities in different functional assays. J Exp Med 158:822–835PubMedGoogle Scholar
  134. Tagami H, Ofiyi S (1976) Leukotactic properties of soluble substances in psoriasis scale. Br J Dermatol 95:1–8PubMedGoogle Scholar
  135. Takematsu M, Suzuki R, Tagami H, Kumagai K (1986) Interleukin-1 like activity in horny layer extracts: decreased activity in scale extracts of psoriasis and sterile pustular dermatosis. Dermatologica 172:236–240PubMedGoogle Scholar
  136. Taniguchi T, Matsui H, Fujita T, et al. (1983) Structure and expression of a cloned cDNA for human interleukin-2. Nature 302:305–310PubMedGoogle Scholar
  137. Ternowitz T (1986) Monocyte and neutrophil chemotaxis in psoriasis. Relation to the clinical status and the type of psoriasis. J Am Acad Dermatol 15:1191–1199PubMedGoogle Scholar
  138. Tew J-Y, Thorbecke GJ, Steinman RM (1981) Dendritic cells in the immune response: characteristics and recommended nomenclature. J Reticuloendothel Soc 31:371–380Google Scholar
  139. Trechsel U, Evequoz V, Fleisch H (1985) Stimulation of interleukin 1 and 3 production by retinoic acid in vitro. Biochem J 230:339–344PubMedGoogle Scholar
  140. Umetsu DT, Pober JS, Jabova HH, et al. (1985) Human dermal fibroblasts present tetanus toxoid antigen to antigen-specific T cell clones. J Clin Invest 76:254–260PubMedGoogle Scholar
  141. Van Hooff JP, Leunissen RML, Staak WVD (1985) Cyclosporin and psoriasis. Lancet 1:335–342PubMedGoogle Scholar
  142. Van Joost T, Heule F, Stolz E, et al. (1986) Short-term use of cyclosporin A in severe psoriasis. Br J Dermatol 114:615–620PubMedGoogle Scholar
  143. Van Joost T, Stolz E, Heule F (1987) Efficacy of low-dose cyclosporine in severe atopic skin disease. Arch Dermatol 123:166–167PubMedGoogle Scholar
  144. Veninga TS, de Doer JC (1986) Urinary excretion pattern of serotonin and 5-hydroxyin-dole acetic acid in ultraviolet induced erythema. J Invest Dermatol 50:1–8Google Scholar
  145. Wainberg MA, Portnoy JD, Clecner B, et al. (1985) Viral inhibition of lymphocyte proliferative responsiveness in patients suffering from recurrent lesions caused by Herpes Simplex virus. J Infect Dis 152:441–448PubMedGoogle Scholar
  146. Waksman BH, Namba Y (1976) On soluble mediators of immunologic regulation. Cell Immunol 21:161–176PubMedGoogle Scholar
  147. Walsh LJ, Seymour GJ, Powel RN (1985) The in vitro effect of retinol on human gingival epithelium. II. Modulation of Langerhans cell markers and interleukin-1 production. J Invest Dermatol 85:501–506PubMedGoogle Scholar
  148. Wang A, Lu S-D, Mark DF (1984) Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. Science 224:1421–1433Google Scholar
  149. Watson JS (1981) Lymphokines and the induction of immune responses. Transplantation 31:313–317PubMedGoogle Scholar
  150. Wentzell JM, Baughman RD, O’Connor GT, Bernier GM (1987) Cyclosporine in the treatment of psoriasis. Arch Dermatol 123:163–165PubMedGoogle Scholar
  151. Whiteside TL, Worrall JG, Buckingham RB, Rodnan GP (1987) Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients. Arthritis Rheum 28:188–197Google Scholar
  152. Widmer MB, Grabstein KH (1987) Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor. Nature 326:795–798PubMedGoogle Scholar
  153. Wolfsy D, Murphy ED, Roths JB, Dauphine MJ, Kipper SB, Talal N (1981) Deficient IL-2 activity in MRL/MP and C57B2/6J mice bearing the lpr gene. J Exp Med 154:1671–1680Google Scholar
  154. Yokota T, Otsuka T, Mosmann T, et al. (1986) Isolation and characterization of a human interleukin cDNA clone, homologous to mouse B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities. Proc Natl Acad Sci USA 83:5894–5898PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • K. A. Brown
  • B. A. Ellis
  • D. C. Dumonde

There are no affiliations available

Personalised recommendations